Private Equity
Anges Québec and Fonds régionaux de solidarité FTQ (FRS) have agreed to partner in sourcing startup investment opportunities in Québec. Under the terms of the partnership, the two groups will refer opportunities to each other. This is expected to result in seed financings led by Anges Québec and potential follow-on rounds that include FRS. FRS may also co-invest in other Anges Québec deals. Based in Montréal, FRS is a regional funds network managed by Fonds de solidarité des travailleurs du Québec FTQ. Anges Québec is a network of 160 private investors that back early-stage companies.
3 min read · 08 October 2014
OpenView Venture Partners said it had raised a $250 million fund, its fourth, amid a strong environment for venture fundraising.
1 min read · 08 October 2014
Multinational computer technology company Dell Inc has launched its Dell for Entrepreneurs program in Canada. The program, which is partnering with Canadian accelerator platform HIGHLINE, will provide Canadian startups with access to technology, sales enablement, capital, networking, education and marketing. Canadian entrepreneurs will also be able to participate in Dell Founders 50, a recurring two-year business acceleration program.
5 min read · 07 October 2014
According to an SEC Form D filing, San Francisco-based Data Collective has raised almost $140 million for its third venture fund. The company invests in early-stage big data companies. Zachary Bogue and Matt Ocko serve as the firm's co-managing partners.
1 min read · 07 October 2014
Pittsbugh-based Innovation Works has raised nearly $24 million for its newest fund Riverfront Ventures. The pool's LPs include the Commonwealth of Pennsylvania, Carnegie Mellon University, the City of Pittsburgh, the University of Pittsburgh and the Pittsburgh Foundation. Riverfront Ventures focuses on local early-stage tech firms from a variety of sectors, such as information technology, medical devices, healthcare IT and robotics.
3 min read · 06 October 2014
According to an SEC Form D filing, North Atlantic Capital is seeking to raise $50 million for its fifth venture fund. The firm typically invests in early-stage tech firms.
1 min read · 06 October 2014
TVM Capital Life Science said Monday that it has raised more than $201.6 million in the final close of its latest fund, TVM Life Science Ventures VII.
1 min read · 06 October 2014
TVM Capital Life Science, a global venture capital firm with an office in Montréal, has closed its TVM Life Science Ventures VlI. Focusing on achieving human clinical proof-of-concept for early-stage drug development projects, Fund VII raised US$201.6 million from cornerstone investors Teralys Capital and Eli Lilly and Co, as well as the Business Development Bank of Canada (BDC), Minnesota Life Insurance Co, CD Venture, Fondaction CSN and a number of pharmaceutical companies. Fund VII targets 12 to 15 project-focused-companies and up to five traditional, syndicated venture capital investments. Earlier this year, it invested in Montréal's PRCL Research Inc, a special purpose company that develops pharmaceutical assets.
5 min read · 06 October 2014
Performance at IVP XII, Clarus Lifesciences II improves last year
2 min read · 06 October 2014
Nokia makes first investment in sector as corporate funds aim to jump into driver’s seat
4 min read · 06 October 2014
